Terms: = Uterine cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Prognosis
1352 results:
1. Sesamolin serves as an MYH14 inhibitor to sensitize endometrial cancer to chemotherapy and endocrine therapy via suppressing MYH9/GSK3β/β-catenin signaling.
Lin Y; Chen X; Lin L; Xu B; Zhu X; Lin X
Cell Mol Biol Lett; 2024 May; 29(1):63. PubMed ID: 38698330
[TBL] [Abstract] [Full Text] [Related]
2. N6-methyladenosine methylation on FSCN1 mediated by METTL14/IGF2BP3 contributes to human papillomavirus type 16-infected cervical squamous cell carcinoma.
Tian Q; Huang J; Zhang Q; Zhao J
Clin Exp Pharmacol Physiol; 2024 Jun; 51(6):e13864. PubMed ID: 38679464
[TBL] [Abstract] [Full Text] [Related]
3. Prevalence of high-risk human papillomavirus infection among women with diabetes mellitus in Accra, Ghana.
Atiase Y; Effah K; Mawusi Wormenor C; Tekpor E; Aku Catherine Morkli E; Boafo E; Yorke E; Aryee R; Essel NOM; Danyo S; Kemawor S; Akpalu J
BMC Womens Health; 2024 Apr; 24(1):260. PubMed ID: 38664791
[TBL] [Abstract] [Full Text] [Related]
4. Fibroblast Growth Factor 23 is a Potential Prognostic Biomarker in uterine Sarcoma.
Yang L; Cai Y; Wang Y; Huang Y; Zhang C; Ma H; Zhou JG
Technol Cancer Res Treat; 2024; 23():15330338241245924. PubMed ID: 38613349
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic and therapeutic potential of STAT3: Opportunities and challenges in targeting HPV-mediated cervical carcinogenesis.
Janjua D; Thakur K; Aggarwal N; Chaudhary A; Yadav J; Chhokar A; Tripathi T; Joshi U; Senrung A; Bharti AC
Crit Rev Oncol Hematol; 2024 May; 197():104346. PubMed ID: 38608913
[TBL] [Abstract] [Full Text] [Related]
6. A comprehensive review on the functional role of miRNA clusters in cervical cancer.
Sriharikrishnaa S; John FE; Bairy M; Shetty S; Suresh PS; Kabekkodu SP
Epigenomics; 2024 Apr; 16(7):493-511. PubMed ID: 38511231
[TBL] [Abstract] [Full Text] [Related]
7. Leukocytoclastic Vasculitis Localized to the uterine Cervix.
Roble JG; Ligon SE; Langan KL
Hawaii J Health Soc Welf; 2024 Mar; 83(3):81-84. PubMed ID: 38456159
[TBL] [Abstract] [Full Text] [Related]
8. The expression analysis of human endogenous retrovirus-K Env, Np9, and Rec transcripts in cervical cancer.
Soleimani-Jelodar R; Arashkia A; Shoja Z; Akhavan S; Yarandi F; Sharifian K; Farahmand M; Nili F; Jalilvand S
J Med Virol; 2024 Mar; 96(3):e29501. PubMed ID: 38445563
[TBL] [Abstract] [Full Text] [Related]
9. Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
Yasutake N; Yamamoto H; Kuga R; Jiromaru R; Hongo T; Katayama Y; Sonoda K; Yahata H; Kato K; Oda Y
Histopathology; 2024 Jun; 84(7):1178-1191. PubMed ID: 38445509
[TBL] [Abstract] [Full Text] [Related]
10. Advanced detection of cervical cancer biomarkers using engineered filamentous phage nanofibers.
Zhou X; Wang Y; Bao M; Chu Y; Liu R; Chen Q; Lin Y
Appl Microbiol Biotechnol; 2024 Feb; 108(1):221. PubMed ID: 38372795
[TBL] [Abstract] [Full Text] [Related]
11. Circular RNAs and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of HPV-related cervical neoplasms.
Heydarnia E; Dorostgou Z; Hedayati N; Mousavi V; Yahyazadeh S; Alimohammadi M; Gheibi M; Heidari P; Igder S; Mafi A; Vakili O
Cell Commun Signal; 2024 Feb; 22(1):107. PubMed ID: 38341592
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic Impact of Heat Shock Protein 90 Expression in Women Diagnosed with Cervical cancer.
Vogelsang TLR; Schmoeckel E; Topalov NE; Ganster F; Mahner S; Jeschke U; Vattai A
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338850
[TBL] [Abstract] [Full Text] [Related]
13.
Zhang YT; Xu LJ; Li L
Genet Test Mol Biomarkers; 2024 Jan; 28(1):10-21. PubMed ID: 38294357
[No Abstract] [Full Text] [Related]
14. Autophagy-related risk signature based on CDNK2A to facilitate survival prediction of patients with endometrial cancer.
Yue C; Lin B; Sun X; Xu X; Zhou C; Fan J
J Gene Med; 2024 Jan; 26(1):e3648. PubMed ID: 38282156
[TBL] [Abstract] [Full Text] [Related]
15. Evaluation of the Antibacterial, Anti-Cervical cancer Capacity, and Biocompatibility of Different Graphene Oxides.
Castro JI; Payan-Valero A; Valencia-Llano CH; Insuasty D; Rodríguez Macias JD; Ordoñez A; Valencia Zapata ME; Mina Hernández JH; Grande-Tovar CD
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257194
[TBL] [Abstract] [Full Text] [Related]
16. β-hCG secreting uterine PEComa.
Murphy P; Machlab K; Almohsen S; Fratesi J; Watson G
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38216169
[TBL] [Abstract] [Full Text] [Related]
17. HPV16 E6 promoting cervical cancer progression through down-regulation of miR-320a to increase TOP2A expression.
Zhang J; Yu X; Guo Y; Wang D
Cancer Med; 2024 Feb; 13(3):e6875. PubMed ID: 38205938
[TBL] [Abstract] [Full Text] [Related]
18. Cervical lymphoepithelioma-like carcinoma with deficient mismatch repair and loss of SMARCA4/BRG1: a case report and five related cases.
Miyama Y; Kato T; Sato M; Yabuno A; Hasegawa K; Yasuda M
Diagn Pathol; 2024 Jan; 19(1):6. PubMed ID: 38178127
[TBL] [Abstract] [Full Text] [Related]
19. Systematic pan-cancer analysis of RNF186 with potential implications in progression and prognosis in human cancer.
Hu Y; Jiang N; Wang X; Wu X; Bo J; Chen Y; Zeng Y; Wei X; Zhang H; Li M
Life Sci; 2024 Feb; 338():122389. PubMed ID: 38160786
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic significance and immunological role of HPRT1 in human cancers.
Lu Y; Chen R; Zhang H; Sun X; Li X; Yang M; Zhang X
Biomol Biomed; 2024 Mar; 24(2):262-291. PubMed ID: 38159260
[TBL] [Abstract] [Full Text] [Related]
[Next]